CCR2 and interstitial lung disease: Kentaro and colleagues conducted a mass cytometry analysis of immune cell subsets in BALF from patients with IPF and found that CD14+ CD36hi CD84hi CCR2– monocytes were increased in patients with IPF and the progressive phenotype of ILD (69).